期刊文献+

卡维地洛和依那普利联用治疗慢性充血性心力衰竭的疗效观察 被引量:1

下载PDF
导出
摘要 目的观察卡维地洛和依那普利对慢性充血性心力衰竭(CHF)的临床疗效及安全性。方法将84例CHF患者随机分为两组,对照组应用地高辛或毛花苷、呋塞米等治疗,在患者耐受的情况下,治疗组在对照组基础上均从小剂量逐步加用卡维地洛和依那普利。观察治疗前后心功能、左室射血分数(EF)、6min步行试验(6-MWT)及不良反应等。结果治疗组的心功能疗效总有效率为71.4%,对照组为52.4%;两组患者用药后的EF、6MWT值均较用药前有明显的提高,其提高值治疗组更显著。结论卡维地洛和依那普利联合治疗可提高疗效,明显改善CHF患者的远期预后。
作者 顾正南
出处 《中国实用医药》 2009年第1期149-150,共2页 China Practical Medicine
  • 相关文献

参考文献2

二级参考文献20

  • 1The Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the befa-blocker bucindilol in patients with advanced chronic heart failare[ J]. N Engl J Med,2001,344(22) : 1659-1667.
  • 2Ruffolo RR Jr, Feuerstein GZ, Ohlstein EH. Resent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failare [ J]. Am J Hypertens, 1998,11 [ 1 Pt 2] :95.
  • 3Yue TL, Mckerma PJ, Lysko PG, et al. SB211 475, a metabolite of carvedilol, a novel antihypertensive a gent, is a potent antioxidant [ J].Eur J Pharmacol, 1994,251 (2-3) :237.
  • 4Sung CP, Arleth A J, Ohlstein EH. Carvedilol inhibits vascular smooth muscle cell proliferation [ J ]. J Cardiovase Pharmacol, 1993,31 ( 2 ) :221.
  • 5Ohlstein EH, Douglas SA, Sung CP, et al. Carvediol, a cardiovascular drug, Prevents vascular smooth muscle cell proliferation, Migration, and neointimal formation following vascular injury [J] .Proc Nail Acad SciUSA, 1993,90(13) :6189.
  • 6Lowes BD, Gill EA, Abroham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure[J] .Am J Cardio, 1999,83(8) : 1201-1205.
  • 7Azevedo ER, Toshihiko kubo, Sasanna Mak. Nonselective versus selective β-adrenergic receptor differentiap effects on sympathetic Activity[J]. Circulation ,2001,104(18) :2194-2199.
  • 8MERIT-HF Study Group. Effect of metopmlolc R/XL in chronic heart failure: Metopmlol CR/XL Randomized Interventional Trial in Corgestive Heart Failure (MERIT-HF) [ J ]. Lancet, 1999, 353 ( 9169 ) : 2001-2007.
  • 9Packer M, Bfistow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failare. US carvedilol Heart Failare Study Group[ J]. N Engl J Med, 1996, 334(21 ) : 1349-1355.
  • 10CIBIS Investigators and commtees. A randomiced trial of β blockade in heart failure the Cardic Insufficiency Bisoprolol Study(CIBIS) [ J]. Circulation, 1994,90(4) : 1765.

共引文献2414

同被引文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部